Osteoarthritis Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Report Highlights
Global Osteoarthritis Drugs Market: Overview
This report analyzes the current and future scenario of the global osteoarthritis drugs market for the period 2018 to 2026. Rise in geriatric population, prevalence of obesity, high unmet medical needs, and rich pipeline are likely to be major drivers of the global osteoarthritis drugs market during the forecast period.
The global osteoarthritis drugs market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on drug class, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global osteoarthritis drugs market.
Global Osteoarthritis Drugs Market: Key Segments
Based on drug class, the global osteoarthritis drugs market has been segmented into corticosteroids, NSAIDs & others, and viscosupplementation agents. The segments have been analyzed based on available drugs used during the treatment of osteoarthritis, and cost-effectiveness. In terms of route of administration, the global osteoarthritis drugs market has been classified into oral, parenteral, and topical. Based on distribution channel, the global osteoarthritis drugs market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.
Global Osteoarthritis Drugs Market: Regional Outlook
In terms of region, the global osteoarthritis drugs market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in the Report
The report also profiles major players operating in the global osteoarthritis drugs market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Horizon Pharma plc, Pfizer Inc., Sanofi, Anika Therapeutics Inc., Ferring B.V., Bioventus Inc, Chugai Pharmaceutical Co. Limited, Alkem Laboratories, Flexion Therapeutics Inc., and Zimmer Biomet Holdings Inc.
The global osteoarthritis drugs market has been segmented as below:
Global Osteoarthritis Drugs Market, by Drug Class
Corticosteroids
NSAIDs & Others
Viscosupplementation Agents
Global Osteoarthritis Drugs Market, by Route Of Administration
Oral
Parenteral
Topical
Global Osteoarthritis Drugs Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Osteoarthritis Drugs Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
- Table 1 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 2 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 3 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 4 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
- Table 5 : North America Osteoarthritis Drugs Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 6 : North America Osteoarthritis Drugs Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 7 : North America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 8 : North America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
- Table 9 : Europe Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 10 : Europe Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 11 : Europe Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 12 : Europe Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 13 : Asia Pacific Osteoarthritis Drugs Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 14 : Asia Pacific Osteoarthritis Drugs Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 15 : Asia Pacific Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 16 : Asia Pacific Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 17 : Latin America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 18 : Latin America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 19 : Latin America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 20 : Latin America Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 21 : Middle East & Africa Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 22 : Middle East & Africa Osteoarthritis Drugs Value (US$ Mn) Forecast, by Drug Class, 2016–2026
- Table 23 : Middle East & Africa Osteoarthritis Drugs Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
- Table 24 : Middle East & Africa Osteoarthritis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Figure 1 : Global Osteoarthritis Drugs Market Snapshot
- Figure 2 : Global Fluid Management Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
- Figure 3 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast, 2016?2026
- Figure 4 : Global Osteoarthritis Drugs Market Value Share, by Drug Class (2017)
- Figure 5 : Global Osteoarthritis Drugs Market Value Share, by Route of Administration (2017)
- Figure 6 : Global Osteoarthritis Drugs Market Value Share, by Distribution Channel (2017)
- Figure 7 : Global Osteoarthritis Drugs Market Value Share, by Region (2017)
- Figure 8 : Global Osteoarthritis Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
- Figure 9 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids
- Figure 10 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Others
- Figure 11 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viscosupplementation Agents
- Figure 12 : Global Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 13 : Global Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 14 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2016–2026
- Figure 15 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2016–2026
- Figure 16 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2016–2026
- Figure 17 : Global Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 18 : Global Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 19 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
- Figure 20 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2016–2026
- Figure 21 : Global Osteoarthritis Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2016–2026
- Figure 22 : Global Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 23 : Global Osteoarthritis Drugs Market Value Share Analysis, by Region 2017 and 2026
- Figure 24 : Global Osteoarthritis Drugs Market Attractiveness, by Region, 2018–2026
- Figure 25 : North America Osteoarthritis Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
- Figure 26 : North America Osteoarthritis Drugs Market Value Share (%), by Drug Class, 2017 and 2026
- Figure 27 : North America Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 28 : North America Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 29 : North America Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 30 : North America Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 31 : North America Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 32 : North America Osteoarthritis Drugs Market Value Share (%), by Country, 2017 and 2026
- Figure 33 : North America Osteoarthritis Drugs Market Attractiveness, by Country, 2018–2026
- Figure 34 : Europe Osteoarthritis Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
- Figure 35 : Europe Osteoarthritis Drugs Market Value Share (%), by Drug Class, 2017 and 2026
- Figure 36 : Europe Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 37 : Europe Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 38 : Europe Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 39 : Europe Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 40 : Europe Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 41 : Europe Osteoarthritis Drugs Market Value Share (%), by Country/Sub-region, 2017 and 2026
- Figure 42 : Europe Osteoarthritis Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
- Figure 43 : Asia Pacific Osteoarthritis Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
- Figure 44 : Asia Pacific Osteoarthritis Drugs Market Value Share (%), by Drug Class, 2017 and 2026
- Figure 45 : Asia Pacific Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 46 : Asia Pacific Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 47 : Asia Pacific Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 48 : Asia Pacific Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 49 : Asia Pacific Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 50 : Asia Pacific Osteoarthritis Drugs Market Value Share (%), by Country/Sub-region, 2017 and 2026
- Figure 51 : Asia Pacific Osteoarthritis Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
- Figure 52 : Latin America Osteoarthritis Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
- Figure 53 : Latin America Osteoarthritis Drugs Market Value Share (%), by Drug Class, 2017 and 2026
- Figure 54 : Latin America Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 55 : Latin America Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 56 : Latin America Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 57 : Latin America Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 58 : Latin America Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 59 : Latin America Osteoarthritis Drugs Market Value Share (%), by Country/Sub-region, 2017 and 2026
- Figure 60 : Latin America Osteoarthritis Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
- Figure 61 : Middle East & Africa Osteoarthritis Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
- Figure 62 : Middle East & Africa Osteoarthritis Drugs Market Value Share (%), by Country/Sub-region, 2017 and 2026
- Figure 63 : Middle East & Africa Osteoarthritis Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
- Figure 64 : Middle East & Africa Osteoarthritis Drugs Market Value Share (%), by Drug Class, 2017 and 2026
- Figure 65 : Middle East & Africa Osteoarthritis Drugs Market Attractiveness, by Drug Class, 2018–2026
- Figure 66 : Middle East & Africa Osteoarthritis Drugs Market Value Share (%), by Route of Administration, 2017 and 2026
- Figure 67 : Middle East & Africa Osteoarthritis Drugs Market Attractiveness, by Route of Administration, 2018–2026
- Figure 68 : Middle East & Africa Osteoarthritis Drugs Market Value Share (%), by Distribution Channel, 2017 and 2026
- Figure 69 : Middle East & Africa Osteoarthritis Drugs Market Attractiveness, by Distribution Channel, 2018–2026
- Figure 70 : Global Osteoarthritis Drugs Market Share Analysis, by Company (2017)
- Figure 71 : Horizon Pharma plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
- Figure 72 : Horizon Pharma plc. Breakdown of Net Sales, by Region, 2017
- Figure 73 : Horizon Pharma plc. Breakdown of Net Sales, by Drug, 2017
- Figure 74 : Horizon Pharma plc. Research & Development Cost (US$ Mn), 2015–2017
- Figure 75 : Pfizer Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
- Figure 76 : Pfizer Inc. R&D Expenses (US$ Mn), 2014–2017
- Figure 77 : Sanofi Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
- Figure 78 : Sanofi Breakdown of Net Sales, by Region, 2017
- Figure 79 : Sanofi Breakdown of Net Sales, by Business Segment, 2017
- Figure 80 : Sanofi Research & Development Cost, 2015–2017 (US$ Mn)
- Figure 81 : Anika Therapeutics, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
- Figure 82 : Anika Therapeutics, Inc. Breakdown of Net Sales, by Region, 2017
- Figure 83 : Anika Therapeutics, Inc. Breakdown of Net Sales, by Business Segment, 2017
- Figure 84 : Anika Therapeutics, Inc. Research & Development Cost, 2015–2017 (US$ Mn)
- Figure 85 : Chugai Pharmaceutical Co., Limited. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
- Figure 86 : Chugai Pharmaceutical Co., Limited. Breakdown of Net Sales, by Region, 2017
- Figure 87 : Chugai Pharmaceutical Co., Limited. Breakdown of Net Sales, by Business Segment, 2017
- Figure 88 : Chugai Pharmaceutical Co., Limited. Research & Development Cost (US$ Mn), 2015–2017
- Figure 89 : Alkem Laboratories Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
- Figure 90 : Alkem Laboratories Breakdown of Net Sales, by Region, 2017
- Figure 91 : Alkem Laboratories Breakdown of Net Sales, by Business Segment, 2017
- Figure 92 : Alkem Laboratories Research & Development Cost (US$ Mn), 2015–2017
- Figure 93 : Zimmer Biomet Holdings, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
- Figure 94 : Zimmer Biomet Holdings, Inc. Breakdown of Net Sales, by Region, 2017
- Figure 95 : Zimmer Biomet Holdings, Inc. Breakdown of Net Sales, by Business Segment, 2017
- Figure 96 : Zimmer Biomet Holdings, Inc. Research & Development Cost (US$ Mn), 2015–2017
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.